Organogenesis Holdings (ORGO) Cash from Operations (2016 - 2026)

Organogenesis Holdings' Cash from Operations history runs 11 years deep, the most recent figure standing at 21127000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations rose 205.98% year-over-year to 21127000.0 in Q1 2026; TTM through Mar 2026 was 30753000.0, a 593.42% increase from a year earlier, with the FY2025 full-year figure at 10309000.0, down 172.56% from the prior year.
• Cash from Operations fell to 21127000.0 in Q1 2026 per ORGO's latest filing, from 39420000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 39420000.0 in Q4 2025 and bottomed at 32873000.0 in Q2 2025.
• The 5-year median for Cash from Operations is 7800000.0 (2022), against an average of 4753058.82.
• Biggest YoY gain for Cash from Operations was 260.43% in 2025; the steepest drop was 793.82% in 2025.
• Year by year, Cash from Operations stood at 7800000.0 in 2022, then jumped by 36.08% to 10614000.0 in 2023, then climbed by 3.04% to 10937000.0 in 2024, then surged by 260.43% to 39420000.0 in 2025, then tumbled by 46.41% to 21127000.0 in 2026.
• Per Business Quant, the three latest ORGO Cash from Operations figures stand at 21127000.0 (Q1 2026), 39420000.0 (Q4 2025), and 3079000.0 (Q3 2025).